Explore the latest news and updates in the field of pancreatic cancer research. Stay informed about the cutting-edge research conducted by Kreftforeningens Nasjonale Ekspertgruppe for Pancreaskreftforskning (KNEP).
Oddmund Nordgård from Stavanger University Hospital presented new results at the annual meeting of the European Liquid Biopsy Society (ELBS), which was held in Barcelona 26-27. November. The ELBS is a dynamic network consisting of partners from academia and industry with the common goal of bringing LB tests into clinical routine
The Project Board of KNEP is grateful for the generous memorial donation by the Voldbakken family. The donation will be used for research into a new model for pancreatic cancer which has been developed by Prof Anders Molven and his group at the University of Bergen. The model attempts to explain how certain genetic changes can lead to the development of pancreatic cancer.
The results of a new study by the Pathology work package were presented at the annual meeting of the Norwegian Pathology Society. The study shows that pathology evaluation of the effect of neoadjuvant treatment of pancreatic cancer, is only reliable if tumour regression is extensive, while lesser degrees of treatment effect cannot be identified with certainty. Maia Blomhoff Holm (to the right on the photograph), who presented the study, was awarded the “Research prize 2024 – best free paper”. Read the publication here.